Cargando…

The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review

The aim of the present systematic review is to examine the role of fluorodeoxyglucose (FDG) positron emission tomography (PET) associated with computed tomography (CT) or magnetic resonance imaging (MRI) in assessing response to preoperative chemotherapy or chemoradiotherapy (CRT) for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evangelista, Laura, Zucchetta, Pietro, Moletta, Lucia, Serafini, Simone, Cassarino, Gianluca, Pegoraro, Nicola, Bergamo, Francesca, Sperti, Cosimo, Cecchin, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197718/ https://www.ncbi.nlm.nih.gov/pubmed/34047926 http://dx.doi.org/10.1007/s12149-021-01629-0

Ejemplares similares

PET/MRI in prostate cancer: a systematic review and meta-analysis
por: Evangelista, Laura, et al.
Publicado: (2020)

Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
por: Evangelista, Laura, et al.
Publicado: (2021)

PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms
por: Moletta, Lucia, et al.
Publicado: (2018)

[18F]FDG PET/MRI in rectal cancer
por: Crimì, Filippo, et al.
Publicado: (2021)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer
por: Sperti, Cosimo, et al.
Publicado: (2020)

The Role of Positron Emission Tomography in Clinical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas
por: Serafini, Simone, et al.
Publicado: (2020)

[(18)F]FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantation
por: Zucchetta, Pietro, et al.
Publicado: (2022)

[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases
por: Evangelista, Laura, et al.
Publicado: (2022)

Recent Advances in Pancreatic Neoplasms
por: Sperti, Cosimo, et al.
Publicado: (2021)

Pancreatic resection in very elderly patients: A critical analysis of existing evidence
por: Sperti, Cosimo, et al.
Publicado: (2017)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

(18)F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature
por: Evangelista, Laura, et al.
Publicado: (2020)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

An Incidental Pancreatic Finding at 18F-Choline PET/CT: Chronic Mass-Forming Pancreatitis
por: Evangelista, Laura, et al.
Publicado: (2021)

MRI and FDG PET/CT Findings for Borderline Brenner Tumor of the Ovary: A Case Report and Literature Review
por: Matsutani, Hiroki, et al.
Publicado: (2020)

Does Pancreatic Fistula Affect Long-Term Survival after Resection for Pancreatic Cancer? A Systematic Review and Meta-Analysis
por: Grego, Andrea, et al.
Publicado: (2021)

Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review
por: Poletto, Giulia, et al.
Publicado: (2022)

The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
por: Palmerini, Emanuela, et al.
Publicado: (2016)

FDG PET/CT of COVID-19
por: Zou, Sijuan, et al.
Publicado: (2020)

Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, (18)F-FDG PET/MRI and CA 19–9
por: Yoo, Jeongin, et al.
Publicado: (2023)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging
por: Boellaard, Ronald, et al.
Publicado: (2010)

Evolving role of FDG-PET/CT in prognostic evaluation of resectable gastric cancer
por: De Raffele, Emilio, et al.
Publicado: (2017)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2012)

Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer
por: Al-Ibraheem, Akram, et al.
Publicado: (2009)

The role of FDG-PET/CT in gynaecological cancers
por: Rockall, Andrea G, et al.
Publicado: (2012)

Lymphomatoid Granulomatosis: CT and FDG-PET Findings
por: Chung, Jonathan H., et al.
Publicado: (2011)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

The Importance of FDG-PET/CT in Cogan’s Syndrome
por: Örsal, Ebru, et al.
Publicado: (2014)

Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)

Usefulness of FDG PET/CT in the management of tuberculosis
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2019)

Role of FDG PET/CT in Baastrup's disease
por: Subramanyam, Padma, et al.
Publicado: (2016)

FDG PET/CT Findings in Biliary Papillomatosis
por: Tu, Zhuolong, et al.
Publicado: (2020)

FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer
por: Lee, Hwanhee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p0oo4pjvsopv73gpl6mmus7dmm